Dr Aaron Mitchell Mullane, MD | |
670 Leigh Dr, Columbus, MS 39705-3014 | |
(662) 328-1012 | |
(662) 328-1507 |
Full Name | Dr Aaron Mitchell Mullane |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 7 Years |
Location | 670 Leigh Dr, Columbus, Mississippi |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396279550 | NPI | - | NPPES |
200003901 | Medicaid | MS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 29669 (Mississippi) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Kindred At Home | Columbus, MS | Home health agency |
Baptist Memorial Hospital Golden Triangle Inc | Columbus, MS | Hospital |
Och Regional Medical Center | Starkville, MS | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The Columbus Orthopaedic Clinic, P.a. | 5890751945 | 28 |
News Archive
"Medicare fraud runs rampant in Miami-Dade" while federal experts examine how the crime spreads among different ethnic communities in different cities, The Associated Press/Miami Herald reports
Mutations in the gene ANT1 may confer a risk for bipolar disorder through a complex interplay between serotonin and mitochondrial signaling in the brain.
MDS Inc., a leading provider of products and services to the global health sciences markets, today announced that it has completed the divestiture of its MDS Pharma Services Early Stage business.
Celator Pharmaceuticals, a privately held pharmaceutical company developing new and more effective therapies to treat cancer based on the company's proprietary technology, today announced that it raised $20 million in a Series D private equity financing.
Pfizer Inc. today announced, at the request of the U.S. Food and Drug Administration (FDA), the suspension of the chronic low back pain and painful diabetic peripheral neuropathy studies in the clinical program for the investigational compound tanezumab. Investigation of the compound continues in some areas of high unmet medical need, including cancer pain.
› Verified 9 days ago
Entity Name | Mississippi Sports Medicine & Orthopaedic Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1568415560 PECOS PAC ID: 4981685310 Enrollment ID: O20040601000238 |
News Archive
"Medicare fraud runs rampant in Miami-Dade" while federal experts examine how the crime spreads among different ethnic communities in different cities, The Associated Press/Miami Herald reports
Mutations in the gene ANT1 may confer a risk for bipolar disorder through a complex interplay between serotonin and mitochondrial signaling in the brain.
MDS Inc., a leading provider of products and services to the global health sciences markets, today announced that it has completed the divestiture of its MDS Pharma Services Early Stage business.
Celator Pharmaceuticals, a privately held pharmaceutical company developing new and more effective therapies to treat cancer based on the company's proprietary technology, today announced that it raised $20 million in a Series D private equity financing.
Pfizer Inc. today announced, at the request of the U.S. Food and Drug Administration (FDA), the suspension of the chronic low back pain and painful diabetic peripheral neuropathy studies in the clinical program for the investigational compound tanezumab. Investigation of the compound continues in some areas of high unmet medical need, including cancer pain.
› Verified 9 days ago
Entity Name | The Columbus Orthopaedic Clinic, P.a. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740287374 PECOS PAC ID: 5890751945 Enrollment ID: O20110331000380 |
News Archive
"Medicare fraud runs rampant in Miami-Dade" while federal experts examine how the crime spreads among different ethnic communities in different cities, The Associated Press/Miami Herald reports
Mutations in the gene ANT1 may confer a risk for bipolar disorder through a complex interplay between serotonin and mitochondrial signaling in the brain.
MDS Inc., a leading provider of products and services to the global health sciences markets, today announced that it has completed the divestiture of its MDS Pharma Services Early Stage business.
Celator Pharmaceuticals, a privately held pharmaceutical company developing new and more effective therapies to treat cancer based on the company's proprietary technology, today announced that it raised $20 million in a Series D private equity financing.
Pfizer Inc. today announced, at the request of the U.S. Food and Drug Administration (FDA), the suspension of the chronic low back pain and painful diabetic peripheral neuropathy studies in the clinical program for the investigational compound tanezumab. Investigation of the compound continues in some areas of high unmet medical need, including cancer pain.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Aaron Mitchell Mullane, MD 670 Leigh Dr, Columbus, MS 39705-3014 Ph: (626) 328-1012 | Dr Aaron Mitchell Mullane, MD 670 Leigh Dr, Columbus, MS 39705-3014 Ph: (662) 328-1012 |
News Archive
"Medicare fraud runs rampant in Miami-Dade" while federal experts examine how the crime spreads among different ethnic communities in different cities, The Associated Press/Miami Herald reports
Mutations in the gene ANT1 may confer a risk for bipolar disorder through a complex interplay between serotonin and mitochondrial signaling in the brain.
MDS Inc., a leading provider of products and services to the global health sciences markets, today announced that it has completed the divestiture of its MDS Pharma Services Early Stage business.
Celator Pharmaceuticals, a privately held pharmaceutical company developing new and more effective therapies to treat cancer based on the company's proprietary technology, today announced that it raised $20 million in a Series D private equity financing.
Pfizer Inc. today announced, at the request of the U.S. Food and Drug Administration (FDA), the suspension of the chronic low back pain and painful diabetic peripheral neuropathy studies in the clinical program for the investigational compound tanezumab. Investigation of the compound continues in some areas of high unmet medical need, including cancer pain.
› Verified 9 days ago
Dr. James Albert Hurt Iii, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 670 Leigh Dr, Columbus, MS 39705 Phone: 662-328-1012 Fax: 662-328-1507 | |
Dr. Russell C. Linton, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 670 Leigh Dr, Columbus, MS 39705 Phone: 662-328-1012 Fax: 662-328-1507 | |
Dr. Gordon Scott Jones, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 670 Leigh Dr, Columbus, MS 39705 Phone: 662-328-1012 Fax: 662-328-1507 | |
Justin Michael Hall, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 670 Leigh Dr, Columbus, MS 39705 Phone: 662-328-1012 Fax: 662-328-1507 | |
Dr. Charles S. Rhea Jr., MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 670 Leigh Dr, Columbus, MS 39705 Phone: 662-328-1012 Fax: 662-328-1507 | |
Dr. George Christopher Galjour, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 670 Leigh Dr, Columbus, MS 39705 Phone: 662-328-1012 |